AC-262536
Also known as: AC-262,536, Accadine, Accadrine
Classification
Sarm
Regulatory Status
not-established
Sources
2
Review
n/a
Overview
Preclinical literature describes AC-262536 as a non-steroidal selective androgen receptor partial agonist with tissue-selective anabolic signals in rodent models. Human mechanism and clinical effect are not established.
Evidence and limitations
Human/preclinical evidence breakdown is not available in this record.
Pathways
Interactions & cautions
Drug interactions
other androgens, anabolic steroids, or SARMs — Additive androgen-receptor activity and unknown stacked toxicity are plausible; no specific interaction trials exist. (high)
These are observational flags for review, not individualized instructions.
Sources
Educational reference only — not medical advice.
What people report (anecdote)
CLINICAL DATA (from trials)
Adverse events:
None recorded in our sources.
Effects measured:
Human trials: none found.
ANECDOTE
What people report: anecdote, not evidence
Loading…
Submit a claim you saw